| Dr Leslie C Doctor, MD | |
|
129 Kings Hwy N, Westport, CT 06880-2438 | |
| (203) 227-4113 | |
| Not Available |
| Full Name | Dr Leslie C Doctor |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 35 Years |
| Location | 129 Kings Hwy N, Westport, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780769968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 033750 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctor And Associates, Pc | 3577590504 | 3 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
The U.S. Food and Drug Administration (FDA) is stepping up its efforts to improve the safety and security of the nation's drug supply through the use of radio frequency identification (RFID) technology.
Massachusetts General Hospital (MGH) clinical researchers, in collaboration with basic scientists from the University of California, Irvine (UC Irvine) have identified a new molecular pathway required for normal development of the reproductive, olfactory and circadian systems in both humans and mice.
New research from Texas A&M University and the University of Pennsylvania on opioid prescribing practices across the country after outpatient knee surgeries found that prescription strength and number of tablets is prescribed highest in Oklahoma and lowest in Vermont.
› Verified 6 days ago
| Entity Name | Doctor & Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053599571 PECOS PAC ID: 3577590504 Enrollment ID: O20050721000514 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
The U.S. Food and Drug Administration (FDA) is stepping up its efforts to improve the safety and security of the nation's drug supply through the use of radio frequency identification (RFID) technology.
Massachusetts General Hospital (MGH) clinical researchers, in collaboration with basic scientists from the University of California, Irvine (UC Irvine) have identified a new molecular pathway required for normal development of the reproductive, olfactory and circadian systems in both humans and mice.
New research from Texas A&M University and the University of Pennsylvania on opioid prescribing practices across the country after outpatient knee surgeries found that prescription strength and number of tablets is prescribed highest in Oklahoma and lowest in Vermont.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leslie C Doctor, MD 129 Kings Hwy N, Westport, CT 06880-2438 Ph: (203) 227-4113 | Dr Leslie C Doctor, MD 129 Kings Hwy N, Westport, CT 06880-2438 Ph: (203) 227-4113 |
News Archive
Æterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia (BPH), with cetrorelix pamoate.
The U.S. Food and Drug Administration (FDA) is stepping up its efforts to improve the safety and security of the nation's drug supply through the use of radio frequency identification (RFID) technology.
Massachusetts General Hospital (MGH) clinical researchers, in collaboration with basic scientists from the University of California, Irvine (UC Irvine) have identified a new molecular pathway required for normal development of the reproductive, olfactory and circadian systems in both humans and mice.
New research from Texas A&M University and the University of Pennsylvania on opioid prescribing practices across the country after outpatient knee surgeries found that prescription strength and number of tablets is prescribed highest in Oklahoma and lowest in Vermont.
› Verified 6 days ago
Dr. Spiro Combest, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 129 Kings Hwy N, Westport, CT 06880 Phone: 203-227-4113 Fax: 203-226-6718 | |
Dr. Jane Roberta Lubin, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 11 Edge Hill Ln, Westport, CT 06880 Phone: 203-222-9321 | |
Dr. Michael Jose Bautista, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 129 Kings Hwy N, Westport, CT 06880 Phone: 203-227-4113 Fax: 203-226-6718 | |
Dr. David Neil Tucker, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 18 Hermit Ln, Westport, CT 06880 Phone: 203-227-6582 Fax: 203-227-0745 | |
Dr. Claudia P Castiblanco, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 129 Kings Hwy N, Westport, CT 06880 Phone: 203-227-4113 | |
Dr. Jessica K Flanagan, D.O. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 129 Kings Hwy North, Westport, CT 06880 Phone: 203-227-4113 |